• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

Put a HALO Over Your Portfolio With My Top Pick for the Second Quarter

The charts of this biotech name are setting up impressively right now.
By BRUCE KAMICH
Mar 30, 2022 | 06:30 AM EDT
Stocks quotes in this article: HALO

Halozyme Therapeutics (HALO) is a biopharmaceutical company "bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies". We last covered HALO on March 4, 2021 where we wrote that, "I will assume that traders took profits on HALO on strength in the $48 to $55 area. HALO now looks like it can correct to the $34 to $30 area in the weeks ahead. Stand aside."

Let's check out the charts again as HALO is my "top pick" for the second quarter.  

In the daily bar chart of HALO, below, we can see that HALO did decline to the $34-$30 area making a triple bottom around $32 since December. Prices have rallied above the 50-day moving average line and the 200-day moving average line. The slope of the 50-day line has turned positive (bullish).
 
The daily On-Balance-Volume (OBV) line shows improvement from December as traders have shifted from being aggressive sellers to aggressive buyers. The Moving Average Convergence Divergence (MACD) oscillator is bullish. 
 
 
 
In the weekly Japanese candlestick chart of HALO, below, we can see that the shares are breaking the downtrend of the past year and have pushed up above the 40-week moving average line. We can see a bullish engulfing pattern in February to mark a bottom reversal.
 
The weekly OBV line is starting to slowly improve and the MACD oscillator has made a cover shorts buy signal. 
 
 
 
In this daily Point and Figure chart of HALO, below, we can see a potential upside price target of $56. A breakout over $56 is likely to open the way to further gains. 
 
 
 
 
Bottom-line strategy: Traders could buy HALO in the $40-$38 area or on strength. Risk to $35 for now. The $56 area is our price objective for now.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Biotechnology | Life Sciences | Pharmaceuticals

More from Stocks

First Citizens BancShares Helped, but Can't Save This Market

James "Rev Shark" DePorre
Mar 27, 2023 4:27 PM EDT

We're still in a trading-range market with many risks ahead.

Jumping Juniper Networks? How to Play the Stock That Looks Ready to Rally

Bruce Kamich
Mar 27, 2023 3:24 PM EDT

Let's check out the charts and indicators.

Could Pioneer Natural Resources Rally Soon?

Bruce Kamich
Mar 27, 2023 1:58 PM EDT

Here's what aggressive traders could do.

Take a Fresh Look at Where You Put Your Cash

Peter Tchir
Mar 27, 2023 12:40 PM EDT

Let's get back to the basics of cash reallocation and see why I'm not freaking out, but I'm also not in a mood for risk.

Why Market Indexes Are Often a Poor Measure of What's Really Going On

James "Rev Shark" DePorre
Mar 27, 2023 11:55 AM EDT

We are witnessing one of the most extreme disconnects in decades between the Nasdaq 100 and Russell 2000.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:00 PM EDT CHRIS VERSACE

    AAP Podcast: This Solar Company Is a Head-Turner

    Listen to my interview with Brian Roth, CEO of sol...
  • 01:56 PM EDT PETER TCHIR

    Very Cautious

    I am very cautious here. I don't like how the c...
  • 08:58 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How to Adjust Your Trading Style as Market Conditi...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login